Posts by Sandra Ansanay-Alex
Swiss Health Valley Biotechs Advance Drug Pipelines with Promising Clinical Milestones
Three innovative biotech companies based in Western Switzerland, Stalicla, Legacy Healthcare and iOnctura, have recently achieved significant progress in their therapeutic pipelines, reinforcing the region’s position as a hub for health innovation. STALICLA: Advancing Precision Medicine for Autism Geneva-based STALICLA has received the green light from the U.S. Food and Drug Administration (FDA) to initiate…
Read MoreRelief Therapeutics is preparing a reverse merger with NeuroX, the successor to MindMaze
The merger must take the form of an exchange of all NeuroX shares for newly issued shares in Relief. The transaction, which is expected to be finalised before the end of the year, would value the Geneva-based company at CHF 100 million and its future partner at CHF 1 billion. The Geneva-based pharmaceutical company…
Read MoreAzureCell Therapies and Myriad Optics Awarded by Gebert Rüf Stiftung Innobooster Programme
Two Swiss Health Valley projects, from EPFL and University of Geneva, got a CHF 150’000 Innobooster grant from Gebert Rüf Stiftung programme: AzureCell Therapies and Myriad Optics. AzureCell Therapies | Bilal Fares, University of Geneva Every 9 min, a new patient is diagnosed with Parkinson’s, a condition long considered incurable due to the irreversible loss…
Read MoreBreaking Through Cancer’s Soft Defense: A Revolutionary Swiss Approach
Swiss researchers from EPFL, University of Geneva, and HUG hospitals are pioneering a groundbreaking strategy to overcome immunotherapy resistance by targeting cancer cells’ physical properties rather than their biology. The project received a CHF 1,4 million grant from Foundation Leenaards. “Our approach targets the mechanical properties of cancer cells by making their membranes stiffer, which…
Read Moreplanetary Switzerland: Scaling Mycoprotein Production Through Strategic Expansion
Geneva-based biomanufacturing platform planetary is making significant strides in the alternative protein sector through a combination of strategic acquisitions, IP breakthroughs, retail partnerships, and government-backed expansion plans. The company has positioned itself as continental Europe’s only viable industrial mycoprotein producer, leveraging cutting-edge fermentation technology to create sustainable protein alternatives. Strategic Acquisition of Libre Foods…
Read MoreTwo UNIGE researchers receive ERC grants
Prof. Pedro Herrera and Prof. Giuseppe Iacobucci both receive €150,000 in funding from the European Research Council (ERC) The European Research Council (ERC) announced the first group of researchers who will receive ERC Proof of Concept Grants in 2025. Two scientists from UNIGE are among those selected. Pedro Herrera, Professor in the Department of Genetic…
Read MoreNestlé Partners with IBM Research to Use AI in New Packaging Developments
Nestlé R&D is partnering with IBM Research to develop new tools that leverage the power of Artificial Intelligence and deep tech to bring breakthrough innovations to life. This research collaboration has led to the development of a generative AI tool that can identify novel high-barrier packaging materials. Packaging helps to protect food and beverages while also preventing food waste. Nestlé tries to…
Read MoreDay One Innovation Showcase
The Day One Innovation Showcase for healthtech promising startups is taking place on 10 and 11 December 2025 in Basel The Showcase is an elite event, tailor-made for investors, startups and potential industry clients, fostering networking, pitching, business exploration and a deep dive into the healthtech startup ecosystem. During the two-day program you…
Read MoreADM Opens R&D Center Dedicated to Animal Health and Wellness at Biopôle
Located ar Biopôle Lausanne in canton of Vaud, the new innovation hub will focus on advanced microbiome research for farm and companion animals ROLLE, Switzerland—ADM (NYSE: ADM), a global leader in innovative solutions from nature, has opened a new research and development (R&D) center focused on advancing research into animal microbiomes, and developing tailored…
Read MoreFirst Ventures
Apply before 1 February 2026 to First Ventures and get up to CHF 150’000 from Gebert Rüf Stiftung With «First Ventures», Gebert Rüf Stiftung supports bachelor’s and master’s students of Swiss Universities of Applied Sciences UAS who are developing an innovative business idea out of their studies towards the market. The support includes progressing contributions…
Read More